Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao-En Xu

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
AI Zheng = Aizheng = Chinese Journal of Cancer|October 15, 2008
[Tumor proteomics: the past, present and future]Xiao-En Xu, Ying-Hua Jiang, Qian Shi
Annals of Translational Medicine|February 12, 2020
eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triple-negative breast cancerRuo-Xi Wang, Xiao-En Xu, Liang Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast CancerYi-Rong Liu, Yi-Zhou Jiang, Xiao-En Xu, et al.
Cancer Research|May 2, 2023
Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast CancerWen-Ting Peng, Xi Jin, Xiao-En Xu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 21, 2015
Loss of TIM50 suppresses proliferation and induces apoptosis in breast cancerShui-Ping Gao, He-Fen Sun, Hong-Lin Jiang, et al.
Theranostics|January 8, 2019
Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast CancerXi-Yu Liu, Ding Ma, Xiao-En Xu, et al.
Oncotarget|October 28, 2015
Loss of COX5B inhibits proliferation and promotes senescence via mitochondrial dysfunction in breast cancerShui-Ping Gao, He-Fen Sun, Hong-Lin Jiang, et al.
Cancer Research|February 28, 2016
Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic ValueYi-Zhou Jiang, Yi-Rong Liu, Xiao-En Xu, et al.
Molecular Cancer|May 13, 2020
LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancerXi Jin, Li-Ping Ge, Da-Qiang Li, et al.
Cancer|May 9, 2020
Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategiesDing Ma, Yi-Zhou Jiang, Yi Xiao, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
AI Zheng = Aizheng = Chinese Journal of Cancer|October 15, 2008
[Tumor proteomics: the past, present and future]Xiao-En Xu, Ying-Hua Jiang, Qian Shi
Annals of Translational Medicine|February 12, 2020
eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triple-negative breast cancerRuo-Xi Wang, Xiao-En Xu, Liang Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast CancerYi-Rong Liu, Yi-Zhou Jiang, Xiao-En Xu, et al.
Cancer Research|May 2, 2023
Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast CancerWen-Ting Peng, Xi Jin, Xiao-En Xu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 21, 2015
Loss of TIM50 suppresses proliferation and induces apoptosis in breast cancerShui-Ping Gao, He-Fen Sun, Hong-Lin Jiang, et al.
Theranostics|January 8, 2019
Genomic Landscape and Endocrine-Resistant Subgroup in Estrogen Receptor-Positive, Progesterone Receptor-Negative, and HER2-Negative Breast CancerXi-Yu Liu, Ding Ma, Xiao-En Xu, et al.
Oncotarget|October 28, 2015
Loss of COX5B inhibits proliferation and promotes senescence via mitochondrial dysfunction in breast cancerShui-Ping Gao, He-Fen Sun, Hong-Lin Jiang, et al.
Cancer Research|February 28, 2016
Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic ValueYi-Zhou Jiang, Yi-Rong Liu, Xiao-En Xu, et al.
Molecular Cancer|May 13, 2020
LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancerXi Jin, Li-Ping Ge, Da-Qiang Li, et al.
Cancer|May 9, 2020
Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategiesDing Ma, Yi-Zhou Jiang, Yi Xiao, et al.
Pageof 3